Brian Abrahams
Stock Analyst at RBC Capital
(4.82)
# 470
Out of 4,676 analysts
1812
Total ratings
56.9%
Success rate
15.3%
Average return
Main Sectors:
Stocks Rated by Brian Abrahams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Rated: Buy | $240 → $260 | $220.77 | +17.77% | 201 | Aug 25, 2026 | |
| NMRA Neumora Therapeutics | Maintained: Buy | $5 | $1.50 | +233.33% | 22 | Aug 14, 2026 | |
| KPTI Karyopharm Therapeutics | Maintained: Buy | $8 | $1.92 | +316.67% | 109 | Aug 13, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintained: Buy | $570 | $552.85 | +3.10% | 152 | Aug 12, 2026 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintained: Buy | $36 | $11.31 | +218.30% | 33 | Aug 12, 2026 | |
| DFTX Definium Therapeutics | Rated: Buy | $57 → $66 | $44.81 | +47.29% | 22 | Aug 12, 2026 | |
| PLRX Pliant Therapeutics | Maintained: Hold | $2 | $1.19 | +68.07% | 31 | Aug 11, 2026 | |
| AARD Aardvark Therapeutics | Maintained: Hold | $6 | $7.25 | -17.24% | 9 | Aug 11, 2026 | |
| LKFT Lakefront Biotherapeutics NV | Rated: Hold | $28 → $26 | $29.70 | -12.46% | 59 | Aug 10, 2026 | |
| NRIX Nurix Therapeutics | Reiterated: Buy | $33 → $36 | $26.95 | +33.58% | 11 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $17 | $15.56 | +9.25% | 11 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $30.62 | +30.63% | 4 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $135 | $134.85 | +0.11% | 9 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $23 → $5 | $6.25 | -20.00% | 8 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $0.57 | +75.44% | 7 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 | $9.42 | +38.00% | 27 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $82 → $81 | $60.42 | +34.06% | 34 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $42 | $28.92 | +45.23% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $29 | $13.79 | +110.30% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $14 → $13 | $9.83 | +32.25% | 100 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 | $18.92 | +0.42% | 136 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $115 → $112 | $126.64 | -11.56% | 8 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 → $37 | $30.57 | +21.03% | 15 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $120 → $123 | $148.77 | -17.32% | 213 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $195 → $198 | $153.37 | +29.10% | 93 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $696 → $737 | $833.56 | -11.58% | 82 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $85 | $73.47 | +15.69% | 102 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $22 → $23 | $17.05 | +34.90% | 14 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $99 → $109 | $129.72 | -15.97% | 137 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $128 | $98.08 | +30.51% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39.00 | $50.91 | -23.39% | 1 | Oct 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $15 | $14.08 | n/a | 54 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $288 | $13.52 | n/a | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $8 | $7.44 | n/a | 7 | May 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $2.91 | n/a | 15 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $188 | $442.24 | n/a | 6 | Oct 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $6.21 | n/a | 1 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 | $199.89 | n/a | 1 | May 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $68 | $26.46 | n/a | 2 | May 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $155.23 | n/a | 1 | Apr 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 | $46.62 | n/a | 1 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $47 → $47 | $73.28 | n/a | 2 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8.75 | $15.44 | n/a | 1 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $51.05 | n/a | 1 | Mar 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 | $0.000001 | n/a | 11 | Feb 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $14.97 | n/a | 3 | Feb 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $108.32 | n/a | 1 | Jan 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $5 | $41.22 | n/a | 2 | Nov 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 | $27.10 | n/a | 1 | Nov 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $40.99 | n/a | 1 | Nov 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $122 | $92.90 | n/a | 3 | Nov 1, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $66.12 | n/a | 4 | Sep 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $38.10 | n/a | 1 | Aug 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $265.79 | n/a | 4 | Aug 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $67.92 | n/a | 4 | Aug 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.36 | n/a | 5 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1,233.66 | n/a | 2 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $273.14 | n/a | 2 | Aug 1, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $156.45 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $28.57 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $3.42 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $159.98 | n/a | 1 | Apr 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $46.75 | n/a | 2 | Feb 23, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.40 | n/a | 1 | Jun 25, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.44 | n/a | 1 | Sep 2, 2009 |
Biogen
Aug 25, 2026
Rated: Buy
Price Target: $240 → $260
Current: $220.77
Upside: +17.77%
Neumora Therapeutics
Aug 14, 2026
Maintained: Buy
Price Target: $5
Current: $1.50
Upside: +233.33%
Karyopharm Therapeutics
Aug 13, 2026
Maintained: Buy
Price Target: $8
Current: $1.92
Upside: +316.67%
Vertex Pharmaceuticals
Aug 12, 2026
Maintained: Buy
Price Target: $570
Current: $552.85
Upside: +3.10%
Corbus Pharmaceuticals Holdings
Aug 12, 2026
Maintained: Buy
Price Target: $36
Current: $11.31
Upside: +218.30%
Definium Therapeutics
Aug 12, 2026
Rated: Buy
Price Target: $57 → $66
Current: $44.81
Upside: +47.29%
Pliant Therapeutics
Aug 11, 2026
Maintained: Hold
Price Target: $2
Current: $1.19
Upside: +68.07%
Aardvark Therapeutics
Aug 11, 2026
Maintained: Hold
Price Target: $6
Current: $7.25
Upside: -17.24%
Lakefront Biotherapeutics NV
Aug 10, 2026
Rated: Hold
Price Target: $28 → $26
Current: $29.70
Upside: -12.46%
Nurix Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $33 → $36
Current: $26.95
Upside: +33.58%
Aug 10, 2026
Maintained: Hold
Price Target: $16 → $17
Current: $15.56
Upside: +9.25%
Aug 10, 2026
Maintained: Buy
Price Target: $40
Current: $30.62
Upside: +30.63%
Aug 10, 2026
Maintained: Hold
Price Target: $135
Current: $134.85
Upside: +0.11%
Aug 10, 2026
Upgraded: Hold
Price Target: $23 → $5
Current: $6.25
Upside: -20.00%
Aug 9, 2026
Maintained: Hold
Price Target: $1
Current: $0.57
Upside: +75.44%
Aug 6, 2026
Maintained: Hold
Price Target: $13
Current: $9.42
Upside: +38.00%
Aug 6, 2026
Reiterated: Buy
Price Target: $82 → $81
Current: $60.42
Upside: +34.06%
Aug 6, 2026
Maintained: Buy
Price Target: $40 → $42
Current: $28.92
Upside: +45.23%
Aug 6, 2026
Maintained: Buy
Price Target: $30 → $29
Current: $13.79
Upside: +110.30%
Aug 5, 2026
Rated: Buy
Price Target: $14 → $13
Current: $9.83
Upside: +32.25%
Aug 5, 2026
Maintained: Hold
Price Target: $19
Current: $18.92
Upside: +0.42%
Aug 5, 2026
Maintained: Hold
Price Target: $115 → $112
Current: $126.64
Upside: -11.56%
Aug 4, 2026
Rated: Buy
Price Target: $36 → $37
Current: $30.57
Upside: +21.03%
Aug 4, 2026
Maintained: Hold
Price Target: $120 → $123
Current: $148.77
Upside: -17.32%
Jul 30, 2026
Rated: Buy
Price Target: $195 → $198
Current: $153.37
Upside: +29.10%
Jul 30, 2026
Rated: Hold
Price Target: $696 → $737
Current: $833.56
Upside: -11.58%
Jul 30, 2026
Maintained: Hold
Price Target: $85
Current: $73.47
Upside: +15.69%
Jul 30, 2026
Rated: Buy
Price Target: $22 → $23
Current: $17.05
Upside: +34.90%
Jul 28, 2026
Maintained: Hold
Price Target: $99 → $109
Current: $129.72
Upside: -15.97%
Apr 7, 2026
Maintained: Buy
Price Target: $128
Current: $98.08
Upside: +30.51%
Oct 26, 2025
Maintained: Buy
Price Target: $39.00
Current: $50.91
Upside: -23.39%
Oct 2, 2023
Maintained: Hold
Price Target: $25 → $15
Current: $14.08
Upside: n/a
Oct 28, 2022
Maintained: Hold
Price Target: $288
Current: $13.52
Upside: n/a
May 16, 2022
Maintained: Hold
Price Target: $9 → $8
Current: $7.44
Upside: n/a
Aug 16, 2021
Maintained: Hold
Price Target: $4
Current: $2.91
Upside: n/a
Oct 26, 2017
Reiterated: Hold
Price Target: $188
Current: $442.24
Upside: n/a
Sep 15, 2017
Initiated Coverage: Buy
Price Target: $23
Current: $6.21
Upside: n/a
May 17, 2017
Reiterated: Buy
Price Target: $135
Current: $199.89
Upside: n/a
May 8, 2017
Reiterated: Hold
Price Target: $68
Current: $26.46
Upside: n/a
Apr 27, 2017
Reiterated: Buy
Price Target: $80
Current: $155.23
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $32
Current: $46.62
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $47 → $47
Current: $73.28
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $8.75
Current: $15.44
Upside: n/a
Mar 7, 2017
Reiterated: Hold
Price Target: $8
Current: $51.05
Upside: n/a
Feb 16, 2017
Reiterated: Hold
Price Target: $2.5
Current: $0.000001
Upside: n/a
Feb 9, 2017
Reiterated: Buy
Price Target: $47
Current: $14.97
Upside: n/a
Jan 5, 2017
Reiterated: Buy
Price Target: $42
Current: $108.32
Upside: n/a
Nov 23, 2016
Reiterated: Hold
Price Target: $4 → $5
Current: $41.22
Upside: n/a
Nov 16, 2016
Reiterated: Buy
Price Target: $39
Current: $27.10
Upside: n/a
Nov 16, 2016
Reiterated: Buy
Price Target: $46
Current: $40.99
Upside: n/a
Nov 1, 2016
Reiterated: Buy
Price Target: $122
Current: $92.90
Upside: n/a
Sep 7, 2016
Reiterated: Buy
Price Target: $120
Current: $66.12
Upside: n/a
Aug 25, 2016
Reiterated: Buy
Price Target: n/a
Current: $38.10
Upside: n/a
Aug 25, 2016
Reiterated: Buy
Price Target: n/a
Current: $265.79
Upside: n/a
Aug 22, 2016
Reiterated: Hold
Price Target: n/a
Current: $67.92
Upside: n/a
Aug 8, 2016
Reiterated: Buy
Price Target: n/a
Current: $8.36
Upside: n/a
Aug 8, 2016
Reiterated: Buy
Price Target: n/a
Current: $1,233.66
Upside: n/a
Aug 1, 2016
Reiterated: Hold
Price Target: n/a
Current: $273.14
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: n/a
Current: $156.45
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $28.57
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $3.42
Upside: n/a
Apr 21, 2016
Reiterated: Buy
Price Target: $61
Current: $159.98
Upside: n/a
Feb 23, 2015
Maintained: Hold
Price Target: n/a
Current: $46.75
Upside: n/a
Jun 25, 2012
Downgraded: Hold
Price Target: n/a
Current: $2.40
Upside: n/a
Sep 2, 2009
Downgraded: Hold
Price Target: n/a
Current: $9.44
Upside: n/a